To me that was the most bullish statement Matt made. We are committed to purchase the AMPH insulin for U.S. production so the SNY insulin would indicate a differ/new market.
6 hours ago you said, ""I expectan announcement soon involving Sanofi, Genzyme & Mannkind." If that is so that would mean management is/has been working diligently to increase shareholder value. Within the last 24 hours you posted numerous rants about how management's incompetence is responsible for not increasing shareholder value. Which is it?
Hakan made it clear I the last conference call that they were looking at those countries that accept the FDA approval to launch in their country. Why wouldn't they?
They used the amph insulin in the PIII, that is why they contracted for a constant supply of that FDA approved insulin from amph.
Management made it very clear that the PFE insulin that is in storage is still useable but not yet approved for use in the production of Afrezza. For you to suggest otherwise is misleading.
Looks like a home run....... Finally, a presentation that CLEARLY shows the superiority of Afrezza and the progress of TS.
Aren't you the guy that would use that type of incompetence as reason to support one of your BO theories??
Can you please stop reposting this insignificant "quote " from 4 years ago . You sir are truly deranged.
If Afrezzais is bought out it will have TS and boatload of cash that would be reflected in share price. Do you really need that explained to you?
I don't know if Cedar fun tennis as long or short but I do know Matt never said $9.00. Keep it real.